In U937 and blasts from AML patients, α4β1 and α5β1 mediated the adhesion of cells to fibronectin, and the addition of the Wnt antagonist sFRP induced resistance to daunorubicin 16407823 (183). Here, FN1 is linked to acute myeloid leukemia.